ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Olivier Jegaden
Armand Eker
Pietro Montagna
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jegaden, O.
Right arrow Articles by Mikaeloff, P. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jegaden, O.
Right arrow Articles by Mikaeloff, P. H.

Ann Thorac Surg 1995;59:456-461
© 1995 The Society of Thoracic Surgeons


Articles

Antegrade/retrograde cardioplegia in arterial bypass grafting: Metabolic randomized clinical trial

MD Olivier Jegaden*, MD Armand Eker, MD Pietro Montagna, MD Jean Ossette, PhD Christian Vial, PhD Jeanine Guidollet, MD Philippe H. Mikaeloff

Department of Cardiovascular Surgery, Hôpital Cardiologique, Lyon, France

Accepted for publication October 13, 1994.

* Address reprint requests to Dr Jegaden, Hopital Cardiologique Louis Pradel, 69394 Lyon Cedex 03, France.

The metabolic effects of combined antegrade/retrograde and antegrade cardioplegia on myocardial protection were evaluated and compared in 30 patients who underwent myocardial revascularization. All patients had three-vessel coronary artery disease, and the revascularization was done with exclusive use of arterial grafts (internal mammary artery, gastroepiploic artery). Myocardial protection consisted of oxygenated crystalloid cardioplegia, topical slushed ice, and moderate systemic hypothermia (34°C). The patients were randomly separated into two groups: group A (n = 15), who received antegrade cardioplegia, and group A/R (n = 15), who received combined antegrade/retrograde cardioplegia. There was no significant difference between the two groups concerning preoperative and intraoperative data. After the first dose of cardioplegia, right ventricular temperature was significantly lower in group A/R (15 ± 2° versus 19 ± 5°C; p < 0.05), and there was no significant difference between the two groups in left ventricular temperature. Coronary sinus blood samples were obtained before bypass and 5, 10, and 15 minutes after reperfusion; there was no difference between the two groups concerning lactates, superoxide dismutase, and gluthatione peroxidase. After reperfusion, malondialdehyde levels increased significantly in group A and there was no change in group A/R, with a significant difference between the two groups (at 10 minutes after reperfusion, 0.80 ± 0.20 versus 0.53 ± 0.16 µmol/L; p < 0.05). Right and left ventricular myocardial biopsies were performed before bypass and 15 minutes after reperfusion; there was no significant difference between the two groups concerning adenosine triphosphate and creatine phosphate myocardial concentrations. After reperfusion, spontaneous recovery of heart activity without defibrillation occurred in 14 patients in group A/R and in 9 patients in group A (p < 0.05); there was no atrioventricular block in group A/R and 26% in group A (p < 0.05). Postoperative release of creatine kinase isoenzyme was higher in group A than in group A/R (6 postoperative hours, 21 ± 12 versus 15 ± 5 µg/L; 12 postoperative hours, 20 ± 14 versus 12 ± 5 µg/L; p < 0.05). We conclude that combined antegrade/retrograde cardioplegia provides better and more homogeneous myocardial protection than does antegrade cardioplegia in patients with three-vessel coronary artery disease who undergo myocardial revascularization with exclusive use of arterial grafts.




This article has been cited by other articles:


Home page
MMCTSHome page
M. P. Siegenthaler
Antegrade administration of cardioplegia
MMCTS, January 1, 2005; 2005(0628): mmcts.2004.000695 - mmcts.2004.000695.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. D. Crittenden
Intraoperative metabolic monitoring of the heart: I. Clinical assessment of coronary sinus metabolites
Ann. Thorac. Surg., December 1, 2001; 72(6): S2220 - S2226.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Carrier, L. C. Pelletier, and N. R. Searle
Does Retrograde Administration of Blood Cardioplegia Improve Myocardial Protection During First Operation for Coronary Artery Bypass Grafting?
Ann. Thorac. Surg., November 1, 1997; 64(5): 1256 - 1262.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
I. Birdi, G. D. Angelini, and A. J. Bryan
Biochemical Markers of Myocardial Injury During Cardiac Operations
Ann. Thorac. Surg., March 1, 1997; 63(3): 879 - 884.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1995 by The Society of Thoracic Surgeons.